Details for Patent: 9,907,793
✉ Email this page to a colleague
Which drugs does patent 9,907,793 protect, and when does it expire?
Patent 9,907,793 protects TARGINIQ and is included in one NDA.
This patent has one hundred and thirty-five patent family members in thirty-two countries.
Summary for Patent: 9,907,793
| Title: | Pharmaceutical preparation containing oxycodone and naloxone |
| Abstract: | The invention concerns a storage stable pharmaceutical preparation comprising oxycodone and naloxone for use in pain therapy, with the active compounds being released from the preparation in a sustained, invariant and independent manner. |
| Inventor(s): | Brogmann; Bianca (Ulm, DE), Muhlau; Silke (Biberach, DE), Spitzley; Christof (Elbtal, DE) |
| Assignee: | Purdue Pharma L.P. (Stamford, CT) |
| Application Number: | 15/399,487 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,907,793
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | ⤷ Try a Trial | |||
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,907,793
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 102 15 067 | Apr 5, 2002 |
| Germany | 102 15 131 | Apr 5, 2002 |
International Family Members for US Patent 9,907,793
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 2043 | ⤷ Try a Trial | |||
| African Regional IP Organization (ARIPO) | 2397 | ⤷ Try a Trial | |||
| Argentina | 039378 | ⤷ Try a Trial | |||
| Argentina | 039379 | ⤷ Try a Trial | |||
| Argentina | 090677 | ⤷ Try a Trial | |||
| Argentina | 099437 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
